8-K/A

AMENDMENT NO. 1 TO 8K

Company: PharmaCyte Biotech, Inc.
Filed: March 29, 2010
Period of Report: March 8, 2010
Accession Number: 0001099910-10-000012

View Document ↗ View on SEC.gov ↗